Business Context and Reporting Period
This Form 8-K Current Report was filed by Lifemd, Inc. on February 7, 2022, covering events occurring on February 4, 2022. The filing primarily addresses corporate governance changes regarding the appointment of a Principal Accounting Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel appointments and associated compensation arrangements.
Material Changes
The material change reported is the appointment of Maria Stan as Controller and Principal Accounting Officer, effective February 4, 2022. Ms. Stan had previously served as the Company's Controller since March 2021. She brings over 20 years of experience in accounting and finance, including prior roles at Eventus Advisory Group, Kaplan North America, Ernst & Young, and KPMG.
Compensation and Management Commentary
In connection with her appointment, Ms. Stan entered into an amendment to her employment agreement granting the following long-term incentive awards:
- Restricted Stock Units (RSUs): 15,000 units total.
- 5,000 units vest on the grant date.
- 5,000 units vest on the first anniversary.
- 5,000 units vest on the second anniversary.
- Performance Share Units (PSUs): 50,000 units.
- Vesting is contingent upon achieving key revenue and EBITDA milestones.
- Vesting is also contingent upon share price appreciation milestones.
- The performance period spans four years.
Forfeiture and Change of Control: Unvested awards are forfeited upon departure for any reason. However, in the event of a Change of Control, 100% of the awards vest immediately.
Investor Verification Checklist
- Verify the specific revenue and EBITDA milestones required for the 50,000 Performance Share Units by reviewing the attached Exhibit 10.1 (First Amendment to Employment Agreement).
- Confirm the exact share price appreciation targets defined in the employment agreement.
- Review the full text of the Employment Agreement (Exhibit 10.2) for additional terms regarding Ms. Stan's role and compensation.